Loading...
Lenalidomide Desensitization in Systemic Light-Chain Amyloidosis With Multi-Organ Involvement
Limited therapeutic options are available to amyloid patients treated with many lines of therapy. Although combination therapy using lenalidomide and dexamethasone is an effective sequential regimen for systemic amyloidosis (AL), dexamethasone is often poorly tolerated in patients with cardiac invol...
Na minha lista:
| Udgivet i: | J Clin Med Res |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elmer Press
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4554222/ https://ncbi.nlm.nih.gov/pubmed/26346623 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/jocmr2303e |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|